Literature DB >> 23442321

Prospective analysis of body mass index, physical activity, and colorectal cancer risk associated with β-catenin (CTNNB1) status.

Teppei Morikawa1, Aya Kuchiba, Paul Lochhead, Reiko Nishihara, Mai Yamauchi, Yu Imamura, Xiaoyun Liao, Zhi Rong Qian, Kimmie Ng, Andrew T Chan, Jeffrey A Meyerhardt, Edward Giovannucci, Charles S Fuchs, Shuji Ogino.   

Abstract

Dysregulation of the WNT/β-catenin (CTNNB1) signaling pathway is implicated in colorectal carcinoma and metabolic diseases. Considering these roles and cancer prevention, we hypothesized that tumor CTNNB1 status might influence cellular sensitivity to obesity and physical activity. In clinical follow-up of 109,046 women in the Nurses' Health Study and 47,684 men in the Health Professionals Follow-up Study, there were 861 incident rectal and colon cancers with tissue immunohistochemistry data on nuclear CTNNB1 expression. Using this molecular pathological epidemiology database, we conducted Cox proportional hazards regression analysis using data duplication method to assess differential associations of body mass index (BMI) or exercise activity with colorectal cancer risk according to tumor CTNNB1 status. Greater BMI was associated with a significantly higher risk of CTNNB1-negative cancer [multivariate HR = 1.34; 95% confidence interval (CI), 1.18-1.53 for 5.0 kg/m(2) increment; Ptrend = 0.0001] but not with CTNNB1-positive cancer risk (multivariate HR = 1.07; 95% CI, 0.92-1.25 for 5.0 kg/m(2) increment; Ptrend = 0.36; Pheterogeneity = 0.027, between CTNNB1-negative and CTNNB1-positive cancer risks). Physical activity level was associated with a lower risk of CTNNB1-negative cancer (multivariate HR = 0.93; 95% CI, 0.87-1.00 for 10 MET-h/wk increment; Ptrend = 0.044) but not with CTNNB1-positive cancer risk (multivariate HR = 0.98; 95% CI, 0.91-1.05 for 10 MET-h/wk increment; Ptrend = 0.60). Our findings argue that obesity and physical inactivity are associated with a higher risk of CTNNB1-negative colorectal cancer but not with CTNNB1-positive cancer risk. Furthermore, they suggest that energy balance and metabolism status exerts its effect in a specific carcinogenesis pathway that is less likely dependent on WNT/CTNNB1 activation. Cancer Res; 73(5); 1600-10. ©2012 AACR. ©2012 AACR.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23442321      PMCID: PMC3594537          DOI: 10.1158/0008-5472.CAN-12-2276

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  50 in total

Review 1.  Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field.

Authors:  Shuji Ogino; Andrew T Chan; Charles S Fuchs; Edward Giovannucci
Journal:  Gut       Date:  2010-10-29       Impact factor: 23.059

2.  Insulin and IGF-1 stimulate the beta-catenin pathway through two signalling cascades involving GSK-3beta inhibition and Ras activation.

Authors:  C Desbois-Mouthon; A Cadoret; M J Blivet-Van Eggelpoël; F Bertrand; G Cherqui; C Perret; J Capeau
Journal:  Oncogene       Date:  2001-01-11       Impact factor: 9.867

Review 3.  Targeting the insulin-like growth factor axis for the development of novel therapeutics in oncology.

Authors:  Jin Gao; Yong S Chang; Bahija Jallal; Jaye Viner
Journal:  Cancer Res       Date:  2012-01-01       Impact factor: 12.701

4.  Serrated lesions of the colorectum: review and recommendations from an expert panel.

Authors:  Douglas K Rex; Dennis J Ahnen; John A Baron; Kenneth P Batts; Carol A Burke; Randall W Burt; John R Goldblum; José G Guillem; Charles J Kahi; Matthew F Kalady; Michael J O'Brien; Robert D Odze; Shuji Ogino; Susan Parry; Dale C Snover; Emina Emilia Torlakovic; Paul E Wise; Joanne Young; James Church
Journal:  Am J Gastroenterol       Date:  2012-06-19       Impact factor: 10.864

5.  Postmenopausal hormone therapy is associated with a reduced risk of colorectal cancer lacking CDKN1A expression.

Authors:  Jennifer H Lin; Teppei Morikawa; Andrew T Chan; Aya Kuchiba; Kaori Shima; Katsuhiko Nosho; Gregory Kirkner; Shumin M Zhang; Joann E Manson; Edward Giovannucci; Charles S Fuchs; Shuji Ogino
Journal:  Cancer Res       Date:  2012-04-17       Impact factor: 12.701

6.  Association of CTNNB1 (beta-catenin) alterations, body mass index, and physical activity with survival in patients with colorectal cancer.

Authors:  Teppei Morikawa; Aya Kuchiba; Mai Yamauchi; Jeffrey A Meyerhardt; Kaori Shima; Katsuhiko Nosho; Andrew T Chan; Edward Giovannucci; Charles S Fuchs; Shuji Ogino
Journal:  JAMA       Date:  2011-04-27       Impact factor: 56.272

Review 7.  Physical activity and risks of proximal and distal colon cancers: a systematic review and meta-analysis.

Authors:  Terry Boyle; Tessa Keegel; Fiona Bull; Jane Heyworth; Lin Fritschi
Journal:  J Natl Cancer Inst       Date:  2012-08-22       Impact factor: 13.506

Review 8.  Aspirin as adjuvant therapy for colorectal cancer--reinterpreting paradigms.

Authors:  Whay Kuang Chia; Raghib Ali; Han Chong Toh
Journal:  Nat Rev Clin Oncol       Date:  2012-08-21       Impact factor: 66.675

9.  Postmenopausal hormone therapy and colorectal cancer risk in relation to somatic KRAS mutation status among older women.

Authors:  Paul J Limburg; David Limsui; Robert A Vierkant; Lori S Tillmans; Alice H Wang; Charles F Lynch; Kristin E Anderson; Amy J French; Robert W Haile; Lisa J Harnack; John D Potter; Susan L Slager; Thomas C Smyrk; Stephen N Thibodeau; James R Cerhan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-02-15       Impact factor: 4.254

Review 10.  Obesity and risk of colorectal cancer: a meta-analysis of 31 studies with 70,000 events.

Authors:  Alireza Ansary Moghaddam; Mark Woodward; Rachel Huxley
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-12       Impact factor: 4.254

View more
  42 in total

1.  High-fat diet induced leptin and Wnt expression: RNA-sequencing and pathway analysis of mouse colonic tissue and tumors.

Authors:  Harrison M Penrose; Sandra Heller; Chloe Cable; Hani Nakhoul; Melody Baddoo; Erik Flemington; Susan E Crawford; Suzana D Savkovic
Journal:  Carcinogenesis       Date:  2017-03-01       Impact factor: 4.944

Review 2.  Molecular pathological epidemiology: new developing frontiers of big data science to study etiologies and pathogenesis.

Authors:  Tsuyoshi Hamada; NaNa Keum; Reiko Nishihara; Shuji Ogino
Journal:  J Gastroenterol       Date:  2016-10-13       Impact factor: 7.527

3.  Mendelian Randomization Study of Body Mass Index and Colorectal Cancer Risk.

Authors:  Aaron P Thrift; Jian Gong; Ulrike Peters; Jenny Chang-Claude; Anja Rudolph; Martha L Slattery; Andrew T Chan; Adam E Locke; Bratati Kahali; Anne E Justice; Tune H Pers; Steven Gallinger; Richard B Hayes; John A Baron; Bette J Caan; Shuji Ogino; Sonja I Berndt; Stephen J Chanock; Graham Casey; Robert W Haile; Mengmeng Du; Tabitha A Harrison; Mark Thornquist; David J Duggan; Loïc Le Marchand; Noralane M Lindor; Daniela Seminara; Mingyang Song; Kana Wu; Stephen N Thibodeau; Michelle Cotterchio; Aung Ko Win; Mark A Jenkins; John L Hopper; Cornelia M Ulrich; John D Potter; Polly A Newcomb; Michael Hoffmeister; Hermann Brenner; Emily White; Li Hsu; Peter T Campbell
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-05-14       Impact factor: 4.254

Review 4.  Focus on genetic and epigenetic events of colorectal cancer pathogenesis: implications for molecular diagnosis.

Authors:  Federica Zoratto; Luigi Rossi; Monica Verrico; Anselmo Papa; Enrico Basso; Angelo Zullo; Luigi Tomao; Adriana Romiti; Giuseppe Lo Russo; Silverio Tomao
Journal:  Tumour Biol       Date:  2014-03-28

Review 5.  The ever-expanding myokinome: discovery challenges and therapeutic implications.

Authors:  Martin Whitham; Mark A Febbraio
Journal:  Nat Rev Drug Discov       Date:  2016-09-12       Impact factor: 84.694

6.  Cys34 Adductomics Links Colorectal Cancer with the Gut Microbiota and Redox Biology.

Authors:  Hasmik Grigoryan; Courtney Schiffman; Marc J Gunter; Alessio Naccarati; Silvia Polidoro; Sonia Dagnino; Sandrine Dudoit; Paolo Vineis; Stephen M Rappaport
Journal:  Cancer Res       Date:  2019-10-22       Impact factor: 12.701

7.  Prognostic Utility of Molecular Factors by Age at Diagnosis of Colorectal Cancer.

Authors:  Nadine J McCleary; Kaori Sato; Reiko Nishihara; Kentaro Inamura; Teppei Morikawa; Xuehong Zhang; Kana Wu; Mai Yamauchi; Sun A Kim; Yasutaka Sukawa; Kosuke Mima; Zhi Rong Qian; Charles S Fuchs; Shuji Ogino; Jeffrey A Meyerhardt
Journal:  Clin Cancer Res       Date:  2015-10-21       Impact factor: 12.531

8.  Survival Benefit of Exercise Differs by Tumor IRS1 Expression Status in Colorectal Cancer.

Authors:  Akiko Hanyuda; Sun A Kim; Alejandro Martinez-Fernandez; Zhi Rong Qian; Mai Yamauchi; Reiko Nishihara; Teppei Morikawa; Xiaoyun Liao; Kentaro Inamura; Kosuke Mima; Yin Cao; Xuehong Zhang; Kana Wu; Andrew T Chan; Edward L Giovannucci; Jeffrey A Meyerhardt; Charles S Fuchs; Ramesh A Shivdasani; Shuji Ogino
Journal:  Ann Surg Oncol       Date:  2015-11-17       Impact factor: 5.344

Review 9.  Body mass index and colorectal cancer prognosis: a systematic review and meta-analysis.

Authors:  B Doleman; K T Mills; S Lim; M D Zelhart; G Gagliardi
Journal:  Tech Coloproctol       Date:  2016-06-24       Impact factor: 3.781

Review 10.  Associations of CYP2E1 rs2031920 and rs3813867 polymorphisms with colorectal cancer risk: a systemic review and meta-analysis.

Authors:  Hui Peng; Shang-Kui Xie; Mei-Jin Huang; Dong-Lin Ren
Journal:  Tumour Biol       Date:  2013-04-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.